Description

The Human VSIG3 / VISTA Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between V-type immunoglobulin domain-containing suppressor of T-cell activation and its receptor V-Set and Immunoglobulin domain containing 3 in the presence of potential inhibitors within 4 hours. 4-8 week development phase.